Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel, Comparative, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

NCT01475578 is registered in ClinicalTrials.gov with Sinphar Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01475578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01475578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel, Comparative, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)
Lead sponsor
Sinphar Pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2002
Completion date
October 31, 2002
Enrollment
240 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

vascular dementia